City
Epaper

Residual cancer linked to worse long-term outcomes: Scientists

By IANS | Updated: March 23, 2025 13:31 IST

New York, March 23 Radiotherapy may leave behind microscopic cancer even when scan images suggest the tumour is ...

Open in App

New York, March 23 Radiotherapy may leave behind microscopic cancer even when scan images suggest the tumour is gone, and this “residual disease” is more common than expected and is linked to worse long-term outcomes, researchers have warned.

Dr Muzamil Arshad from the University of Chicago Medical Center and colleagues highlighted this growing concern in cancer care, in a new editorial published in Oncotarget journal.

Their perspective calls for a rethinking of how treatment success is judged and how cancer is followed up after therapy.

Radiotherapy, especially a form known as stereotactic ablative radiotherapy (SABR), is widely used to treat cancers in the lung, liver, prostate, and other organs.

SABR delivers high-dose radiation with outstanding precision and often shows excellent results on scans.

However, the authors highlighted that relying only on imaging may not provide a complete picture.

Months or even years later, follow-up biopsies frequently reveal cancer cells that scan imaging tests were unable to identify.

“Residual cancer is identified on histology in 40 per cent of lung, 57–69 per cent of renal cell, 7.7–47.6 per cent of prostate and 0–86.7 per cent of hepatocellular carcinoma,” said authors.

This gap between what scans show and what tissue analysis finds can have serious consequences.

Studies across several cancer types have shown that patients with residual disease — even if small — are more likely to experience cancer recurrence and shorter survival.

This pattern holds true for rectal, cervical, prostate, and liver cancers, among others. In some cases, not destroying the tumour completely may allow it to spread to distant organs.

The authors pointed out that a complete response on scan imaging does not necessarily indicate the complete disappearance of the tumour.

The editorial encouraged the cancer care community to look beyond the scan images. Residual cancer may remain even when imaging looks clear, and recognising this hidden threat is key to improving long-term outcomes.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

Other Sports2nd ODI: Short, Connolly fifties guide Australia to series-clinching win over India

NationalBSF apprehends minor with 11 gold biscuits along India-Bangladesh border

TechnologyDPIIT signs MoUs with Kotak Mahindra Bank, Primus Partners to strengthen startup ecosystem

Other SportsIndia’s brightest young squash talents set for action at Sub Junior & Junior Nationals in Chennai

BusinessStovekraft Accelerates Growth with Target of 500 Exclusive Stores by 2027

Technology Realted Stories

TechnologyOver 80 pc women believe more female tech leaders can improve workplace culture: Report

TechnologyIndia’s EV growth accelerates with multi-fuel push: Report

TechnologyCochin Shipyard delivers first indigenous anti-submarine vessel Mahe to Indian Navy

TechnologyDefence Ministry gives nod for buying military hardware worth Rs 79,000 crore

TechnologyISRO to launch US’ BlueBird-6 satellite, weighing 6.5 tonnes by year-end: Dr. V. Narayanan